Get the Stockscreener App
11.19
6.88%
0.72
Pre-market:
11.89
0.70
+6.26%
Inogen Inc stock is traded at $11.19, with a volume of 226.82K.
It is up +6.88% in the last 24 hours and up +31.96% over the past month.
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
See More
Previous Close:
$10.47
Open:
$10.55
24h Volume:
226.82K
Relative Volume:
1.21
Market Cap:
$265.42M
Revenue:
$315.66M
Net Income/Loss:
$-102.45M
P/E Ratio:
-2.5374
EPS:
-4.41
Net Cash Flow:
$-30.25M
1W Performance:
+5.37%
1M Performance:
+31.96%
6M Performance:
+20.97%
1Y Performance:
+109.16%
1-Day Range:
$10.50
$11.26
1-Week Range:
$10.28
$11.26
52-Week Range:
$5.27
$13.33
Inogen Inc Stock (INGN) Company Profile
Name
Inogen Inc
Sector
Industry
Phone
805-562-0500
Address
859 WARD DRIVE, GOLETA, CA
Compare INGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INGN
Inogen Inc
|
11.19 | 265.42M | 315.66M | -102.45M | -30.25M | -4.41 |
|
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-15-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Aug-08-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-14-23 | Downgrade | Needham | Buy → Hold |
| Jan-17-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-09-21 | Upgrade | Needham | Hold → Buy |
| Nov-02-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Aug-05-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-04-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-14-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-23-20 | Downgrade | Needham | Buy → Hold |
| May-06-20 | Reiterated | Needham | Buy |
| Nov-06-19 | Upgrade | Needham | Hold → Buy |
| Sep-13-19 | Reiterated | Piper Jaffray | Overweight |
| Aug-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Aug-08-19 | Downgrade | Stifel | Buy → Hold |
| Aug-07-19 | Downgrade | Needham | Buy → Hold |
| Jun-28-19 | Downgrade | Needham | Strong Buy → Buy |
| May-08-19 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-19 | Reiterated | Needham | Strong Buy |
| Feb-27-19 | Reiterated | Needham | Strong Buy |
| Nov-20-18 | Upgrade | Needham | Buy → Strong Buy |
| Nov-07-18 | Reiterated | Needham | Buy |
| Sep-10-18 | Downgrade | Needham | Strong Buy → Buy |
| Aug-22-18 | Resumed | Stifel | Buy |
| Aug-08-18 | Reiterated | Needham | Strong Buy |
| Jun-06-18 | Initiated | KeyBanc Capital Mkts | Sector Weight |
| May-01-18 | Reiterated | Needham | Strong Buy |
| Feb-28-18 | Reiterated | Needham | Strong Buy |
View All
Inogen Inc Stock (INGN) Latest News
Inogen, Inc. (NASDAQ:INGN) Short Interest Down 6.2% in December - MarketBeat
Inogen Stock Gains Following Solid Preliminary Q4 Revenues - MSN
Barclays PLC Purchases 23,398 Shares of Inogen, Inc. (NASDAQ:INGN) - Defense World
Inogen Insiders Benefitted From Selling Stock At US$8.56 - Simply Wall St
Inogen expects prelim Q4 revenue in the range of $79M to $80M - MSN
Inogen stock holds as revenue forecast beats consensus - Investing.com India
Inogen reports growth in Q4 and full year 2024 revenue By Investing.com - Investing.com Australia
Inogen stock holds as revenue forecast beats consensus By Investing.com - Investing.com Australia
Inogen (NASDAQ:INGN) Given "Hold" Rating at Needham & Company LLC - MarketBeat
Inogen, Inc. Provides Revenue Guidance for the Fourth Quarter of 2024 and Full Year 2024 - Marketscreener.com
Inogen, Inc. (NASDAQ:INGN) Stock Position Increased by JPMorgan Chase & Co. - Defense World
Inogen (NASDAQ:INGN) Stock Crosses Above Fifty Day Moving AverageHere's Why - MarketBeat
Inogen (NASDAQ:INGN) Stock Crosses Above Fifty Day Moving Average – Here’s Why - Defense World
Inogen reports growth in Q4 and full year 2024 revenue - Investing.com India
Inogen Surpasses 2024 Revenue Guidance with 6% Growth, Launches New Respiratory Products - StockTitan
Inogen receives FDA 510(k) clearance for SIMEOX 200 airway clearance device - News-Medical.Net
Jane Street Group LLC Cuts Stake in Inogen, Inc. (NASDAQ:INGN) - Defense World
Jane Street Group LLC Sells 250,473 Shares of Inogen, Inc. (NASDAQ:INGN) - MarketBeat
Geode Capital Management LLC Purchases 5,921 Shares of Inogen, Inc. (NASDAQ:INGN) - Defense World
Franklin Resources Inc. Takes $139,000 Position in Inogen, Inc. (NASDAQ:INGN) - Defense World
Inogen, Inc. (NASDAQ:INGN) Shares Purchased by Barclays PLC - Defense World
FDA OKs Inogen’s Simeox 200 Airway Clearance Device - MPO-mag
Inogen Stock Rises as FDA Clears SIMEOX 200 Airway Clearance Device - MSN
Inogen Expands U.S. Market with FDA Clearance - Yahoo Finance
FDA grants clearance for Inogen’s SIMEOX 200 airway clearance device - Yahoo Finance
Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device - BioSpace
Inogen Gets FDA Clearance for Airway Clearance Device - MarketWatch
Inogen, Inc. (NASDAQ:INGN) Shares Purchased by State Street Corp - Defense World
Inogen's SIMEOX 200 Airway Clearance Device Receives FDA Clearance for Chronic Lung Disease Treatment - StockTitan
Here's Why You Should Retain Inogen Stock in Your Portfolio Now - Nasdaq
StockNews.com Downgrades Inogen (NASDAQ:INGN) to Hold - Defense World
Inogen, Inc. (NASDAQ:INGN) is a favorite amongst institutional investors who own 78% - Yahoo Finance
Inogen, Inc.'s (NASDAQ:INGN) institutional investors lost 12% over the past week but have profited from longer-term gains - Simply Wall St
Short Interest in Inogen, Inc. (NASDAQ:INGN) Grows By 6.7% - MarketBeat
BNP Paribas Financial Markets Increases Stock Position in Inogen, Inc. (NASDAQ:INGN) - Defense World
Inogen (NASDAQ:INGN) Raised to Buy at StockNews.com - Defense World
Respiratory Care Market Set to Witness Significant Growth by 2024-2031:Inogen, Inc., Honeywell International - EIN News
The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen - Yahoo Finance
Oxygen Concentrators Global Market Report: Market - openPR
Inogen Alliance Releases 2023 ESG Report - AccessWire
Respiratory Care Market Projected To Witness Substantial Growth, 2024-2031: Inogen, Inc., Honeywell - EIN News
Inogen (INGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - MSN
INGN (Inogen) Earnings per Share (Diluted) : $-2.25 (TTM As of Sep. 2024) - GuruFocus.com
Connor Clark & Lunn Investment Management Ltd. Buys 132,287 Shares of Inogen, Inc. (NASDAQ:INGN) - MarketBeat
Inogen Inc Stock (INGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):